Researchers launch trial to treat long COVID with drug used to block effects of opioids

ABC Gold Coast
20 December 2022
https://www.abc.net.au/news/2022-12-21/long-covid-treatment-trial-drug-low-dose-naltrexone/101770626?utm_source=abc_news_web&utm_medium=content_shared&utm_campaign=abc_news_web

Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force

Pain Pract
29 October 2022
https://pubmed.ncbi.nlm.nih.gov/36308490/

Antinociceptive effect of ultra-low dose naltrexone in a pre-clinical model of postoperative orofacial pain

Brain Res
04 November 2022
https://pubmed.ncbi.nlm.nih.gov/36335995/

A Comprehensive Review: Chronic Pain Sequelae in the Presence of Ehlers-Danlos Syndrome

Curr Pain Headache Rep
25 November 2022
https://pubmed.ncbi.nlm.nih.gov/36434419/

Natasha - Australia: Chronic Pain and Cancer (LDN; low dose naltrexone)

It’s time for a reckoning in pain medicine

KevinMD.com
17 November 2022
https://www.kevinmd.com/2022/11/its-time-for-a-reckoning-in-pain-medicine.html

More than a million Americans have died since the late 1990s from drug overdoses, with the vast majority dying from an opioid overdose. Substance abuse treatment providers report that 80 percent of illicit opioid users got addicted after being prescribed opioid painkillers.